Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adaptimmune Therapeutics Plc ADR shares valued at $20,244 were sold by Rawcliffe Adrian on Jan 17 ’24. At $0.67 per share, Rawcliffe Adrian sold 30,080 shares. The insider’s holdings dropped to 44,848 shares worth approximately $40363.200000000004 following the completion of this transaction.
Also, Bertrand William C JR sold 18,908 shares, netting a total of over 12,725 in proceeds. Following the sale of shares at $0.67 each, the insider now holds 7,785 shares.
Before that, Norry Elliot had sold 18,276 shares from its account. In a trade valued at $12,300, the Chief Medical Officer traded Adaptimmune Therapeutics Plc ADR shares for $0.67 each. Upon closing the transaction, the insider’s holdings decreased to 18,276 shares, worth approximately $7006.5.
As published in their initiating research note from Bryan Garnier on March 24, 2023, Adaptimmune Therapeutics Plc ADR [ADAP] has been a Buy and the price target has been revised to $3.60. Analysts at Guggenheim upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early January. As of November 09, 2022, Mizuho has increased its “Neutral” rating to a “Buy” for ADAP. Earlier on May 28, 2021, Barclays initiated its rating. Their recommendation was “an Underweight” for ADAP stock.
Analyzing ADAP Stock Performance
During the last five days, there has been a drop of approximately -30.36%. Over the course of the year, Adaptimmune Therapeutics Plc ADR shares have jumped approximately 13.29%. Shares of the company reached a 52-week high of $2.0500 on 03/08/24 and a 52-week low of $0.6517 on 01/17/24. A 50-day SMA is recorded $1.3942, while a 200-day SMA reached $0.8924. Nevertheless, trading volume fell to 3.32 million shares from 1.22 million shares the previous day.
Support And Resistance Levels for Adaptimmune Therapeutics Plc ADR (ADAP)
According to the 24-hour chart, there is a support level at 0.8506, which, if violated, would cause prices to drop to 0.8027. In the upper region, resistance lies at 0.9678. The next price resistance is at 1.0371. RSI (Relative Strength Index) is 25.49 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2700, which suggests the price will decrease in the coming days. Percent R is at 96.12%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
